Evergreening, patent challenges, and effective market life in pharmaceuticals
-
Frequently Asked Questions on USPTO
Pharma Live, , Intellectual Property Rights, 0
What XML resources are available at the USPTO to process bulk data? Bulk data uses different versions of XML...
-
The Nasty Patent Games Drug Companies Play To Stop You From Getting Cheaper Drugs – Courtesy (TechDirt)
Pharma Live, , Intellectual Property Rights, 0
The astoundingly wonderful radio program/podcast Radiolab just recently had an episode called“Worth” — which included a few different stories trying...
-
Suven Life’s NCEs for neurodegenerative diseases receive European & Hong Kong patents – Courtesy(Pharmabiz.com)
Pharma Live, , Intellectual Property Rights, 0
Suven Life Sciences Ltd (Suven), a Hyderabad-based biopharmaceutical company focussed on discovering, developing and commercialising novel pharmaceutical products, has...
-
Wyeth denied patent for cancer drug – Courtesy ( The Financial Express)
Pharma Live, , Intellectual Property Rights, 0
Wyeth, which was acquired by US- based pharma major Pfizer Inc, has suffered a major setback in India with...
-
The Remicade Biosimilar Patent Dispute
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 10 MARCH 2015POSTED IN BIOSIMILARSWhile Sandoz has grabbed the biosimilar headlines for being the first company to have a...
-
Novo Nordisk rejects Baxter patent claim over Novoeight
Pharma Live, , Intellectual Property Rights, 0
COPENHAGEN, May 20 (Reuters) – Novo Nordisk said on Wednesday it rejected claims by U.S. rival Baxter International that...
-
Helping U.S. Patent Applicants Get Speedy Examination – Courtesy (Global IP Matters)
Pharma Live, , Intellectual Property Rights, 0
U.S. patent applicants often have an interest in expediting the patent examination process. The desire to speed examination can...
-
Amicus Briefs On Biosimilar Patent Litigation – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 23 APRIL 2015POSTED IN BIOSIMILARSAmgen has appealed the district court decision denying its motion for a...
![](https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)